Sentinel Lymph Node Biopsy for Recurrent Melanoma: A Multicenter Study.

about

Sentinel Lymph Node Biopsy for Recurrent Melanoma: A Multicenter Study.

Item

http://www.wikidata.org/entity/Q38784286

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Sentinel Lymph Node Biopsy for Recurrent Melanoma: A Multicenter Study.

@en

type

Item

label

Sentinel Lymph Node Biopsy for Recurrent Melanoma: A Multicenter Study.

@en

prefLabel

Sentinel Lymph Node Biopsy for Recurrent Melanoma: A Multicenter Study.

@en

P1476

Sentinel Lymph Node Biopsy for Recurrent Melanoma: A Multicenter Study.

@en

P2093

Alicia M Terando

http://www.w3.org/2001/XMLSchema#string

April K Salama

http://www.w3.org/2001/XMLSchema#string

Douglas S Tyler

http://www.w3.org/2001/XMLSchema#string

J Harrison Howard

http://www.w3.org/2001/XMLSchema#string

Kara Rossfeld

http://www.w3.org/2001/XMLSchema#string

Linda Youngwirth

http://www.w3.org/2001/XMLSchema#string

Randall P Scheri

http://www.w3.org/2001/XMLSchema#string

Syed Gardezi

http://www.w3.org/2001/XMLSchema#string

Yinin Hu

http://www.w3.org/2001/XMLSchema#string

P2860

Overview and update of the phase III Multicenter Selective Lymphadenectomy Trials (MSLT-I and MSLT-II) in melanoma

Localization of the Sentinel Lymph Node in Melanoma Without Blue Dye

One hundred consecutive isolated limb perfusions with TNF-alpha and melphalan in melanoma patients with multiple in-transit metastases.

Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: a multicenter trial. Multicenter Selective Lymphadenectomy Trial Group.

Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma.

The impact on morbidity and length of stay of early versus delayed complete lymphadenectomy in melanoma: results of the Multicenter Selective Lymphadenectomy Trial (I).

Critical analysis of the current American Joint Committee on Cancer staging system for cutaneous melanoma and proposal of a new staging system.

Sentinel-node biopsy or nodal observation in melanoma.

Is sentinel lymph node mapping indicated for isolated local and in-transit recurrent melanoma?

Final Results of the Sunbelt Melanoma Trial: A Multi-Institutional Prospective Randomized Phase III Study Evaluating the Role of Adjuvant High-Dose Interferon Alfa-2b and Completion Lymph Node Dissection for Patients Staged by Sentinel Lymph Node Bi

P2888

s10434-017-5883-6

P304

2728-2733

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1245/S10434-017-5883-6

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Georgia Beasley

Doreen M Agnese

Craig Slingluff

P577

2017-05-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1085414030

http://www.w3.org/2001/XMLSchema#string

P698

28508145

http://www.w3.org/2001/XMLSchema#string